Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
GABAergic Agonists Modulate the Glutamate Release from Frontal Cortex Synaptosomes of Rats with Experimental Autoimmune Encephalomyelitis.
Acupuncture and multiple sclerosis: a review of the evidence.
Systematic review of occupational therapy-related interventions for people with multiple sclerosis: part 1. Activity and participation.
New EMA Advice for PML Prevention With Fingolimod in MS
Isotetrandrine Reduces Astrocyte Cytotoxicity in Neuromyelitis Optica by Blocking the Binding of NMO-IgG to Aquaporin 4.
In-silico prediction of drug targets, biological activities, signal pathways and regulating networks of dioscin based on bioinformatics.
Resolution of central nervous system astrocytic and endothelial sources of CCL2 gene expression during evolving neuroinflammation.
[Therapeutic use of cannabis derivatives].
Abnormal distribution of AQP5 in labial salivary glands is associated with poor saliva secretion in patients with Sjögren's syndrome including neuromyelitis optica complicated patients.
Exploratory Study of the Safety, Tolerability and Efficacy of Multiple Regimens of Natalizumab in Adult Participants With Relapsing Multiple Sclerosis (MS). (REFINE)
Multiple sclerosis: Preventing progression and disability in MS-when to treat?
MRI and neurophysiological measures to predict course, disability and treatment response in multiple sclerosis.
Aquaporin-4 antibody negative recurrent isolated optic neuritis: Clinical evidence for disease heterogeneity.
The Cytokine GM-CSF Drives the Inflammatory Signature of CCR2(+) Monocytes and Licenses Autoimmunity.
TLR4-activated microglia require IFN-γ to induce severe neuronal dysfunction and death in situ.
Brain atrophy and lesion load predict long term disability in multiple sclerosis.
Large-scale neuronal network dysfunction in relapsing-remitting multiple sclerosis.
MicroRNA-150: A potential regulator in pathogens infection and autoimmune diseases.
Protein array-based profiling of CSF identifies RBPJ as an autoantigen in multiple sclerosis.
Developmentally regulated GTP-binding protein 2 ameliorates EAE by suppressing the development of TH17 cells.
Multiple sclerosis: Etiology, incidence and prevalence.
Multiple sclerosis: Grey matter atrophy in the thoracic spinal cord is associated with disability in patients with multiple sclerosis.
Pediatric familial neuromyelitis optica in two sisters with long term follow-up.
A 10-year population-based study of people with multiple sclerosis in Stockholm, Sweden: use of and satisfaction with care and the value of different factors in predicting use of care.
Multiple sclerosis in India: An overview.
Pages
« first
‹ previous
…
488
489
490
491
492
493
494
495
496
…
next ›
last »